Stockchase Opinions

Michael Smedley Aurora Spine ASG-X PAST TOP PICK Mar 24, 2015

(Top Pick Mar 31/14, Down 70.59%) It went up and then went down. It is competing with 10 or 12 others. It will be much better later. The original run up was just speculation.

$1.350

Stock price when the opinion was issued

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK

Patented, approved technology. A Spinal fusion clamp. 50 or so operations completed.

BUY

Medical devices. This is probably one of the better corrections as it has had a phenomenal move. There is a dearth of news on the company. They have FDA approval. Things are kind of slow in hospital orders in the US at the moment. This sounds like an opportunity. A great investment for a retail investor who doesn’t have all that much money.

RISKY

This kind of collapsed in a mysterious way in July. Thinks it went too far, too fast. Wait for the recovery for the company to get its nose and head down and get working on the products, and selling into the US hospital space. Have new products and they are getting serious. Thinks it has now stabilized. Speculatively, it could easily double in the next 12 months.

HOLD

It went too high too fast. They are simply getting down to work now. You have to be a little patient.

HOLD

Have been getting clearance for their spinal devices in the US, England and most recently in Canada. They are in the build process, exhibiting patients, working hard to get into the hospitals, and have launched an additional product. Have about 12 competitors. The stock ran too far, right in the beginning. He will continue to hold.

PAST TOP PICK

(A Top Pick Jan 13/14. Down 66.82%.) Had an amazing initial climb based on the clamping of the spinal vertebrae. Probably just had too much of a push. They are now down into the hard work of selling into the hospital systems in the US, which apparently have turned a bit cautious. Have 12 or 13 competitors.

COMMENT

One of the most disappointing plays. It is kind of at the beginning of this great 2-year bull market in all of these stocks. There are a lot of companies in this sector. They are working hard to try to increase its sales in hospital equipment.

HOLD

It was really unfortunate in that it came out at the peak of interest in the small medical field related companies, and is competing with 12-13 others. It probably will get taken out.

WATCH

It was all " gung ho" about 2 years ago. It is difficult to find out what is going on. Management have been rather shy for a long time. Overall revenues have not risen dramatically for a long time. There are a lot of competitors. He needs to look more closely into the company.